NCT04414059View on ClinicalTrials.gov

Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 10, 2021

Primary Completion Date

May 10, 2022

Study Completion Date

September 10, 2022

Conditions
SARS-CoV 2Hospitalisation-Associated Infection
Trial Locations (2)

Unknown

Clinique de l'Estrée, Stains

Clinique Vauban, Valenciennes

Sponsors

Lead Sponsor

Elsan
All Listed Sponsors
lead

Elsan

OTHER

NCT04414059 - Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients | Biotech Hunter | Biotech Hunter